跳至主要内容
临床试验/CTRI/2018/04/013218
CTRI/2018/04/013218进行中(未招募)3 期

Adjuvant Chemotherapy or Chemo-radiation in Gall Bladder Cancer: A Phase III Randomized Controlled Study (ACCeleRate trial) - cancer,gall bladder,chemotherapy,radiotherapy,ACCeleRate

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
进行中(未招募)

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a.Histologically proven cases of adenocarcinoma of gall bladder
  • b.Patients have undergone radical cholecystectomy by a surgeon with training in gastro-intestinal surgery or a surgical oncologist working in a high-volume center
  • c.Patient has recovered from surgical morbidity
  • d.There is no more than 3 months of time gap between date of radical surgery and start of adjuvant therapy (It is possible to start adjuvant therapy within 3 months of surgery)
  • e.Written consent is obtained
  • f.ECOG Performance status <2
  • g.Age >18 years
  • h.Adequate bone marrow functions reflected as Hemoglobinïâ?¬Â¾ 10gm/dl, TLC ïâ?¬Â¾4,000/cmm(ANCïâ?¬Â¾1,500/cmm), and Platelets ïâ?¬Â¾1,00,000/cmm)
  • i.Serum creatinine ïâ?¬Â¼ 1.8 mg%
  • j.Serum bilirubin ïâ?¬Â¼3 mg%
  • k.Liver enzymes (SGOT and SGPT) within 3 times the upper normal limit
  • l.No prior exposure to oxaliplatin, oxaliplatin, capecitabine or radiation therapy
  • Exclusion criteria

排除标准

  • a.Women of reproductive age group not practicing contraception
  • b.Lactating and pregnant women
  • c.Patients who are on other investigational drugs
  • d.History of previous carcinoma in last 5 yrs.
  • e.Active hepatitis B, C or HIV infection

研究者

相似试验